These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 16299542

  • 1. Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.
    Crowther H, Collins D, Antonenas V, McGurgan M, Kerridge I, Gottlieb D, Bradstock K.
    Bone Marrow Transplant; 2006 Feb; 37(3):329-30. PubMed ID: 16299542
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM.
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [Abstract] [Full Text] [Related]

  • 4. [Bacteremia due to Capnocytophaga spp.: two cases].
    García J, Lizasoain M, Lahuerta JJ, Sanz F.
    Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):168-9. PubMed ID: 12586027
    [No Abstract] [Full Text] [Related]

  • 5. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
    Imamura T, Yoshihara T, Morimoto A, Ishida H, Sugimoto T, Imashuku S.
    Pediatr Hematol Oncol; 2006 Mar; 23(1):19-24. PubMed ID: 16326408
    [Abstract] [Full Text] [Related]

  • 6. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G, Palomera L, Varo MJ, Soria J.
    Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
    [No Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
    Bishton MJ, Haynes AP.
    Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
    [Abstract] [Full Text] [Related]

  • 8. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R, Conde E, Grande C, Mateos MV, Gandarillas M, Albo C, Lahuerta JJ, Fernández-Rañada JM, Hernández MT, Alonso N, García Vela JA, Garzón S, Rodríguez J, Caballero D, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO).
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [Abstract] [Full Text] [Related]

  • 9. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
    Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, Ohno Y, Eto T, Harada M, Nagafuji K.
    Bone Marrow Transplant; 2007 May; 39(9):523-7. PubMed ID: 17369863
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
    Ergene U, Cağirgan S, Pehlivan M, Yilmaz M, Tombuloğlu M.
    Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
    [Abstract] [Full Text] [Related]

  • 11. Acute myocardial ischemia after high-dose therapy with BEAM regimen.
    Genet P, Pulik M, Gallet B, Lionnet F, Jondeau K, Touahri T, Laribi K.
    Bone Marrow Transplant; 2002 Aug; 30(4):253-4. PubMed ID: 12203142
    [Abstract] [Full Text] [Related]

  • 12. Trial of amifostine in autologous stem cell transplant.
    Sastry P, Bhagwat R, Biswas G, Khadwal A, Narayanan P, Bakshi A, Parikh P.
    Bone Marrow Transplant; 2006 Jan; 37(1):117-8. PubMed ID: 16273114
    [No Abstract] [Full Text] [Related]

  • 13. Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
    Ferreri AJ, Bruno Ventre M, Donadoni G, Cattaneo C, Fumagalli L, Foppoli M, Mappa S, Govi S, Di Nicola M, Rossi G, Tirelli U, Caligaris-Cappio F, Spina M, Re A.
    Br J Haematol; 2012 Oct; 159(2):252-5. PubMed ID: 22924636
    [No Abstract] [Full Text] [Related]

  • 14. Unusual implantation site of a port-a-cath system via the right femoral vein.
    Meyer F, Buerger T, Gebauer T, Halloul Z.
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):400-1. PubMed ID: 12136255
    [No Abstract] [Full Text] [Related]

  • 15. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
    Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, Canizo CD, Baker N, Barker P, Skacel T, Schmitz N.
    Haematologica; 2008 Mar; 93(3):405-12. PubMed ID: 18268285
    [Abstract] [Full Text] [Related]

  • 16. Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Farnault L, Venton G, Pourroy B, Jourde-Chiche N, Ivanov V, Arcani R, Roche P, Mercier C, Colle J, Fanciullino R, Costello RT.
    Bone Marrow Transplant; 2019 Jul; 54(7):1173-1175. PubMed ID: 30718799
    [No Abstract] [Full Text] [Related]

  • 17. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
    Shirao S, Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Konuma Y, Hirayama Y, Kohda K.
    Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485
    [Abstract] [Full Text] [Related]

  • 18. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
    Kashyap A, Snowden J.
    J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F, Hölig K, Platzbecker U, Poppe-Thiede K, Ordemann R, Blechschmidt M, Oelschlaegel U, Schaich M, Hänel M, Bornhäuser M, Ehninger G.
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [Abstract] [Full Text] [Related]

  • 20. ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.
    Akhtar S, Tbakhi A, Humaidan H, El Weshi A, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2006 Feb; 37(3):277-82. PubMed ID: 16400345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.